申请人:SCHERING CORPORATION
公开号:EP0322633A1
公开(公告)日:1989-07-05
Novel mercapto-acylamino acids useful in the treatment of hypertension and combinations of mercapto-acylamino acids and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating hypertension are disclosed.
本研究公开了可用于治疗高血压的新型巯基乙酰
氨基酸,以及可用于治疗高血压的巯基乙酰
氨基酸与心房利
钠因子或
血管紧张素转换酶
抑制剂的组合。